PAVmed (PAVM) Receivables - Other (2016 - 2021)

PAVmed's (PAVM) quarterly Receivables - Other came in at $27000.0 in Q1 2021, up 8.0% quarter-over-quarter from $25000.0 in Q1 2016.

PAVmed (PAVM) Receivables - Other (2016 - 2021) Analysis & Trends

PAVmed's Receivables - Other history runs 2 years deep, the most recent figure standing at $27000.0 for Q1 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	PAVmed	9.85 Mn	-3.35 Mn	-4,000.00

Download Data